Company: BIVIW
Filing Date: 2025-07-03
Form Type: S-1
Source: 0001520138-25-000198
Chunk: 46

Company: BIOVIE INC.
Filing Date: 2025-07-03
Form: S-1
Chunk 46
---
 makes it more difficult for other stockholders to replace our board of directors or for a third party
to obtain control of us by replacing our board of directors.

<div align='center'>29

Underwriting</div>

We have entered into an underwriting agreement
dated , 2025 with ThinkEquity LLC, as the representative
of the underwriters (the “Representative”), with respect to the securities sold in this offering. Subject to the terms and
conditions of the underwriting agreement, we have agreed to sell to the underwriters named below, and the underwriters have agreed, severally
and not jointly, to purchase from us the securities set forth opposite the underwriter’s name in the following table at the public
offering price less the underwriting discounts set forth in the cover page of this prospectus:

| Underwriter     |     | Number of 
 Units     |     | Number of        
 Pre-funded Units |
| ThinkEquity LLC |     |           |     |                  |
| Total           |     |           |     |                  |

The underwriters have committed to purchase all
of the securities offered by us other than those covered by the over-allotment option described below, if they purchase any securities.
The obligations of the underwriters may be terminated upon the occurrence of certain events specified in the underwriting agreement. Furthermore,
pursuant to the underwriting agreement, the underwriters’ obligations are subject to customary conditions, representations and warranties
contained in the underwriting agreement, such as receipt by the underwriters of officers’ certificates and legal opinions.

The underwriters are offering the securities,
subject to prior sale, when, as and if issued to and accepted by them, subject to approval of legal matters by their counsel and other
conditions contained in the underwriting agreement. The underwriters reserve the right to withdraw, cancel or modify offers to the public
and to reject orders in whole or in part.

We have agreed to indemnify the underwriters against
specified liabilities, including liabilities under the Securities Act, or to contribute to payments the underwriters may be required to
make in respect of those liabilities.

Over-Allotment Option

We have granted a 45-day option to the underwriters
to purchase up to 218,447 additional shares of Common Stock and/or up to 218,447 additional Pre-funded Warrants and/or up to 218,447
additional Warrants, or any combination thereof, solely to cover over-allotments, if any. The underwriters